U.S. Markets closed

Bristol-Myers Stock Is Falling Because the Celgene Merger May Not Make Sense

Josh Nathan-Kazis

A stormy honeymoon could be in the offing following the biggest pharmaceutical acquisition in history, according to one analyst.